Calming the storm: natural immunosuppressants as adjuvants to target the cytokine storm in COVID-19
AE Peter, BV Sandeep, BG Rao… - Frontiers in …, 2021 - frontiersin.org
The COVID-19 pandemic has caused a global health crisis, with no specific antiviral to treat
the infection and the absence of a suitable vaccine to prevent it. While some individuals …
the infection and the absence of a suitable vaccine to prevent it. While some individuals …
Cardiovascular complications associated with COVID-19 and potential therapeutic strategies
A Samidurai, A Das - International journal of molecular sciences, 2020 - mdpi.com
The outbreak of coronavirus disease 2019 (COVID-19), an infectious disease with severe
acute respiratory syndrome, has now become a worldwide pandemic. Despite the …
acute respiratory syndrome, has now become a worldwide pandemic. Despite the …
Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development
Spike glycoprotein, a class I fusion protein harboring the surface of SARS-CoV-2 (SARS-
CoV-2S), plays a seminal role in the viral infection starting from recognition of the host cell …
CoV-2S), plays a seminal role in the viral infection starting from recognition of the host cell …
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: a randomized controlled trial
One of the main causes of acute respiratory distress syndrome in coronavirus disease 2019
(COVID-19) is cytokine storm, although the exact cause is still unknown. Umbilical cord …
(COVID-19) is cytokine storm, although the exact cause is still unknown. Umbilical cord …
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel …
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel …
Integration of FDOSM and FWZIC under homogeneous Fermatean fuzzy environment: a prioritization of COVID-19 patients for mesenchymal stem cell transfusion
Mesenchymal stem cell (MSC) transfusion has shown promising results in treating COVID-
19 cases despite the limited availability of these MSCs. The task of prioritizing COVID-19 …
19 cases despite the limited availability of these MSCs. The task of prioritizing COVID-19 …
Updated living systematic review and meta-analysis of controlled trials of mesenchymal stromal cells to treat COVID-19: a Framework for Accelerated Synthesis of Trial …
AM Kirkham, AJM Bailey, M Monaghan… - Stem cells …, 2022 - academic.oup.com
Abstract Background Mesenchymal stromal cells (MSCs) may reduce mortality in patients
with COVID-19; however, early evidence is based on few studies with marked interstudy …
with COVID-19; however, early evidence is based on few studies with marked interstudy …
[HTML][HTML] A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19
COVID-19 is caused by SARS-CoV-2, which originated in Wuhan, Hubei province, Central
China, in December 2019 and since then has spread rapidly, resulting in a severe …
China, in December 2019 and since then has spread rapidly, resulting in a severe …
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical …
Background High morbidity and mortality rates of the COVID-19 pandemic have made it a
global health priority. Acute respiratory distress syndrome (ARDS) is one of the most …
global health priority. Acute respiratory distress syndrome (ARDS) is one of the most …
Mesenchymal stem cells and their derived exosomes to combat Covid–19
M Yousefi Dehbidi, N Goodarzi… - Reviews in Medical …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is causing an ongoing
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …
pandemic of coronavirus disease 2019 (Covid‐19). Effective therapies are required for the …